Immunomodulatory and antitumor activities of water-soluble proteoglycan isolated from the fruiting bodies of culinary-medicinal oyster mushroom Pleurotus ostreatus (Jacq.: Fr.) P. Kumm. (agaricomycetideae)

International Journal of Medicinal Mushrooms

Volumn 9, Issue 2, 2007, Pages 123-138

  Shah, Saurabh ^a   Ghosh, Dipanjan ^a   Mallick, Sanjaya Kumar ^a   Sarangi, Itisam ^a   Bhutia, Sujit Kumar ^a   Banerje, Indranil ^a   Maiti, Swatilekha ^a   Maiti, Tapas K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Anticancer; Biological response modifier; Immunomodulatory; Medicinal mushroom; Pleurotus ostreatus; Proteoglycan

Indexed keywords

HYDROGEN PEROXIDE; NITRIC OXIDE; PLANT EXTRACT; PLEUROTUS OSTREATUS EXTRACT; PROTEOGLYCAN; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG ISOLATION; GEL FILTRATION CHROMATOGRAPHY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PLEUROTUS OSTREATUS; PRECIPITATION; PROTEIN ANALYSIS; SARCOMA; SPLEEN CELL; STATISTICAL SIGNIFICANCE; THYMOCYTE;

BASIDIOMYCOTA; PLEUROTUS OSTREATUS;

EID: 34347327092     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v9.i2.30     Document Type: Article

References (32)

1. Anumula K. R. 1994. Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. Anal Biochem, 220, 275-283.
2. Bohn J. A. and BeMiller J. N. 1995. (1-3)-β-D- Glucans as biological response modifiers: a review of structure-function activity relationships. Carbohydr Polym, 28, 3-14.
3. Chen J. J. W., Lin Y. C., Yao P. L., Yuan A., Chen H. Y., Shun C. T., Tsai M. F., Chen C. H., and Yang P. C. 2005. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol, 23, 953-964.
4. Crueger W. and Crueger A. 1990. Biotechnology. In: A textbook of industrial microbiology, Brock T. D., ed., Sinauer Associates Inc., Sunderland, IL, pp. 191-193.
5. Daba A. S. and Ezeronye O. U. 2003. Anti-cancer effect of polysaccharides isolated from higher Basidiomycetes mushrooms. Afr J Biotechnol, 2, 672-678.
6. Galichet A., Sockalingum G. D., Belarbi A., and Manfait M. 2001. FTIR spectroscopic analysis of Saccharomyces cerevisiae cell walls: study of an anomalous strain exhibiting a pink-colored cell phenotype. FEMS Microbiol Lett, 197, 179-186.
7. Gonzaga M. L. C., Ricardo N. G. M. P. S., Heatley F., and Soares S. A. 2005. Isolation and characterization of polysaccharides from Agaricus blazei Murrill. Carbohydr Polym, 60, 43-49.
8. Gutierrez A. P. and Martelnez A. T. 1996. Structural characterization of extracellular polysaccharides produced by fungi from the genus Pleurotus. Carbohydr Res, 281, 143-154.
9. Jong S. and Yang X. 1999. PSP - a powerful biological response modifier from the mushroom Coriolous versicolor. In: Advanced research in PSP. Yang Q., ed., Hong Kong Association for Health Care Ltd., Hong Kong, pp. 16-28.
10. Kidd P. M. 2000. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev, 5, 4-27.
11. Kobayashi H., Matsunaga K., and Oguchi Y. 1995. Antimetastatic effects of PSK (Krestin), a proteinbound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemol Biomarkers Prev, 4, 275-281.
12. Lee S. S., Wei Y. H., Chieh C. F., Wang S. Y., and Chen K. Y. 1995. Antitumor effects of Ganoderma lucidum. J Chin Med, 6, 1-12.
13. Lull C., Wichers H. J., and Savelkoul H. F. J. 2005. Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm, 2, 63-80.
14. Mizuno T. 1996. A development of anti-tumor polysaccharides from mushroom fungi. Food Ingred J Jpn, 167, 69-85.
15. Mizuno T. 1999. The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan. Int J Med Mushr, 1, 9-29.
16. Mosmann T. J. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth, 65, 55-63.
17. Ooi V. E. C. and Liu F. 1999. A review of pharmacological activities of mushroom polysachharides. Int J Med Mushr, 1, 195-206.
18. Ooi V. E. C. and Liu F. 2000. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem, 7, 715-729.
19. Paulik S., Svrcek S., Mojzisova J., Durove A., Benisek Z., and Huska M. 1996. The immunomodulatory effect of the soluble fungal glucan (Pleurotus ostreatus) on delayed hypersensitivity and phagocytic ability of blood leucocytes in mice. J Vet Med B, 43, 129-135.
20. Pramanik M., Mondal S., Chakraborty I., Rout D., and Islam S. S. 2005. Structural investigation of a polysaccharide (Fr. II) isolated from the aqueous extract of an edible mushroom, Pleurotus sajorcaju. Carbohydr Res, 340, 629-636.
21. Rout D., Mondal S., Chakraborty I., and Islam S. S. 2006. The structure of a polysaccharide from fraction-II of an edible mushroom, Pleurotus florida. Carbohydr Res, 341, 995-1002.
22. Rout D., Mondal S., Chakraborty I., Pramanik M., and Islam S. S. 2005. Chemical analysis of a new (1-3)-, (1-6)-branched glucan from an edible mushroom Pleurotus florida. Carbohydr Res, 340, 2533-2539.
23. Sarangi I., Ghosh D., Bhutia S. K., Mallick S. K., and Maiti T. K. 2006. Anti-tumor and immunomodulating effects of Pleurotus ostreatus myceliaderived proteoglycans. Int Immunopharmacol, 6, 1287-1297.
24. Shamtsyan M. M., Konusova V. G., Goloshchev A. M., Maksimova Y. O., Panchenko A. V., Petrishchev N. N., and Denisova N. P. 2004. Immunomodulating and antitumour effects of basidiomycetes Pleurotus ostreatus (Jacq.: Fr.) P. Kumm. and P. cornucopiae (Pau. ex Pers.) Rollan. J Biol Phys Chem, 4, 157-161.
25. Stoscheck C. M. 1990. Quantitation of proteins. Meth Enzymol, 182, 50-69.
26. Wang H. X., Ng T. B., Ooi V. E., Liu W. K., and Chang S. T. 1996. A polysaccharide-peptide complex from cultured mycelia of the mushroom Tricholoma mongolicum with immunoenhancing and anti-tumor activities. Biochem Cell Biol, 74, 95-100.
27. Wasser S. P. 2002a. Medicinal mushrooms as a source of anti-tumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol, 60, 258-274.
28. Wasser S. P. 2002b. Review of medicinal mushrooms advances: good news from old allies. Herbal Gram, 56, 28-33.
29. Wasser S. P. and Weis A. L. 1999a. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol, 19, 65-96.
30. Wasser S. P. and Weis A. L. 1999b. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int J Med Mushr, 1, 31-62.
31. Yoshioka Y., Tabeta R., Saito H., Uehara N., and Fukuoka F. 1985. Antitumor polysaccharides from P. ostreatus (Fr.) Quél.: isolation and structure of a β-glucan. Carbohydr Res, 140, 93-100.
32. Zhang Q. and Lin Z. 1999. Study on antitumor activity and mechanism of Ganoderma polysaccharides B. Zhongguo Zhong Xi Yi Jie He Za Zhi, 19, 544-547.